Deletion of 11q23 is a frequent event in the evolution ofMYCN single-copy high-risk neuroblastomas
- 30 November 2000
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 35 (6) , 544-546
- https://doi.org/10.1002/1096-911x(20001201)35:6<544::aid-mpo10>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group StudyJournal of Clinical Oncology, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasOncogene, 1999
- Molecular Biology of NeuroblastomaJournal of Clinical Oncology, 1999
- Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridizationGenes, Chromosomes and Cancer, 1998
- Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysisEuropean Journal Of Cancer, 1997
- Comparative genomic hybridization study of primary neuroblastoma tumorsGenes, Chromosomes and Cancer, 1997